Published ahead of print on February 10, 2006, doi:10.1164/rccm.200509-1525OC
Am. J. Respir. Crit. Care Med., Volume 173, Number 9, May 2006, 991-998
A more recent version of this article appeared on May 1, 2006
Submitted on September 28, 2005
Accepted on February 10, 2006
Airway Inflammation and Bronchial Bacterial Colonization in Chronic Obstructive Pulmonary Disease
Sanjay Sethi1*, Jane Maloney2, Lori Grove2, Catherine Wrona2, and Charles S Berenson3
1 Department of Medicine, Division of Pulmonary/Critical Care and Sleep Medicine, University at Buffalo, Buffalo, NY, USA; Department of Veterans Affairs, Western New York Healthcare System, Buffalo, NY, USA,
2 Department of Medicine, Division of Infectious Diseases, University at Buffalo, Buffalo, NY, USA,
3 Department of Medicine, Division of Infectious Diseases, University at Buffalo, Buffalo, NY, USA; Department of Veterans Affairs, Western New York Healthcare System, Buffalo, NY, USA
* To whom correspondence should be addressed. E-mail: ssethi{at}buffalo.edu.
Rationale: Inflammation is now recognized as an integral part of the pathogenesis of chronic obstructive pulmonary disease (COPD). In contrast to the sterile airways of normal lungs, bacterial pathogens are often isolated from the airways in stable COPD. This 'colonization' of the tracheobronchial tree, currently thought to be innocuous, could serve as an inflammatory stimulus, independent of current tobacco smoke exposure.
Objective: To test the hypothesis that bacterial 'colonization' is associated with airway inflammation in stable COPD.
Methods: Bronchoscopy with bronchoalveolar lavage (BAL) was performed in three groups of subjects: 26 ex-smokers with stable COPD (COPD), 20 ex-smokers without COPD (ex-smokers) and 15 healthy non-smokers (non-smokers). Quantitative bacterial cultures, cell counts, chemokine, cytokine, proteinase/anti-proteinase and endotoxin levels in the BAL fluid were compared.
Results: Potentially pathogenic bacteria were recovered at 100 colony forming units/ml in 34.6% of COPD, 0% of ex-smokers and in 6.7% of non-smokers [p=0.003]. Colonized COPD subjects had significantly greater relative [12.0(28.4) vs. 3.0(7.8)%, p=0.03] and absolute [4.98(5.26) x 104/ml vs. 3.04(2.82) x 104/ml, p=0.02] neutrophil counts, interleukin-8 [33.8(189.8) vs. 16.9(20.1)pg/ml, p=0.005], active matrix metalloproteinase-9 [2.16(4.30) vs. 0.84(0.99)units/ml, p=0.03] and endotoxin [36.0(72.6) vs. 3.55 7.17)mEU/ml, p=0.004] levels in the BAL than the non-colonized COPD subjects. These inflammatory constituents of BAL were also significantly elevated in colonized COPD subjects when compared to ex-smokers and non-smokers.
Conclusions: Bacterial colonization is associated with neutrophilic airway lumen inflammation in ex-smokers with COPD and could contribute to progression of airway disease in COPD.
Key words: COPD, Bacterial colonization, Neutrophilic inflammation
This article has been cited by other articles:

|
 |

|
 |
 
P. Glader, B. Eldh, S. Bozinovski, K. Andelid, M. Sjostrand, C. Malmhall, G. P. Anderson, G. C. Riise, I. Qvarfordt, and A. Linden
Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space
Eur. Respir. J.,
September 1, 2008;
32(3):
644 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pasqua, G. Biscione, G. Crigna, and M. Cazzola
Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers
Therapeutic Advances in Respiratory Disease,
August 1, 2008;
2(4):
209 - 214.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Albert and P. M. A. Calverley
Drugs (including oxygen) in severe COPD
Eur. Respir. J.,
May 1, 2008;
31(5):
1114 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Pang, D. Winn, R. Johnson, W. Hong, S. West-Barnette, N. Kock, and W. E. Swords
Lipooligosaccharides Containing Phosphorylcholine Delay Pulmonary Clearance of Nontypeable Haemophilus influenzae
Infect. Immun.,
May 1, 2008;
76(5):
2037 - 2043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi, C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T. F. Murphy
Inflammatory Profile of New Bacterial Strain Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
March 1, 2008;
177(5):
491 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Feghali-Bostwick, A. S. Gadgil, L. E. Otterbein, J. M. Pilewski, M. W. Stoner, E. Csizmadia, Y. Zhang, F. C. Sciurba, and S. R. Duncan
Autoantibodies in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
January 15, 2008;
177(2):
156 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Wedzicha, P. M. A. Calverley, T. A. Seemungal, G. Hagan, Z. Ansari, R. A. Stockley, and for the INSPIRE Investigators
The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide
Am. J. Respir. Crit. Care Med.,
January 1, 2008;
177(1):
19 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Abusriwil and R. A. Stockley
The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage
Proceedings of the ATS,
December 1, 2007;
4(8):
611 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy
Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations
Proceedings of the ATS,
December 1, 2007;
4(8):
626 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sykes, P. Mallia, and S. L. Johnston
Diagnosis of Pathogens in Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
December 1, 2007;
4(8):
642 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez
Pathogen-directed Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
December 1, 2007;
4(8):
647 - 658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi, R. Sethi, K. Eschberger, P. Lobbins, X. Cai, B. J. B. Grant, and T. F. Murphy
Airway Bacterial Concentrations and Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
August 15, 2007;
176(4):
356 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri
Update in Chronic Obstructive Pulmonary Disease 2006
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1222 - 1232.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Celli and P. J. Barnes
Exacerbations of chronic obstructive pulmonary disease
Eur. Respir. J.,
June 1, 2007;
29(6):
1224 - 1238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. K. Demedts, K. R. Bracke, G. Van Pottelberge, D. Testelmans, G. M. Verleden, F. E. Vermassen, G. F. Joos, and G. G. Brusselle
Accumulation of Dendritic Cells and Increased CCL20 Levels in the Airways of Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
May 15, 2007;
175(10):
998 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kraft and P. J. Barnes
Beyond the Dutch Hypothesis
Am. J. Respir. Crit. Care Med.,
November 1, 2006;
174(9):
1057 - 1057.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Papi, F. Luppi, F. Franco, and L. M. Fabbri
Pathophysiology of Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2006;
3(3):
245 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society
|
|
|